One moment, please omenizol metronidazole obat apa Killian, who has run the fund since 1997 for Greenwich, Connecticut-based Renaissance Capital, does not simply buy the shares of every new company on its debut. She weighs short-term considerations - such as the new company's valuation compared to its publicly traded peers - and long-term issues, such as whether the company has a unique product or service and the amount of stock held by company executives.
|